Study Evaluating Rimonabant Efficacy in Drug-NAive DiabEtic Patients
Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
Primary: Effect on HbA1c over 6 months in drug-naive patients with type 2 diabetes
Secondary: Effect on glucose, insulin, C-peptide, insulin resistance, body weight,
HDL-cholesterol, triglycerides, blood pressure - Safety, tolerability